Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Google’s chief health officer Karen DeSalvo announced she will retire this summer. DeSalvo, who likes to introduce herself as ...

Hims & Hers Health, Inc.'s subscriber growth, Novo Nordisk partnership, and FDA pill approval could boost financials. Click ...

Hims & Hers Health, Inc. HIMS delivered an earnings per share (EPS) of 20 cents in first-quarter 2025 compared with the ...

Yahoo Finance host Brad Smith tracks today's top moving stocks and biggest market stories in this Market Minute, including ...

There are only a few companies that come around every half-decade or so that really get the gears turning in terms of having ...

Hims & Hers Health ( HIMS) shares surged 8% Tuesday, a day after the health and wellness platform posted better-than-expected ...

Hims & Hers stock has risen by 20% after announcing a partnership to sell the popular weight-loss drug Wegovy.

Hims & Hers Health, Inc.'s Q1 results show 111% growth, yet shares fell 8%. Click for a look at the impact of drug access, ...

The Chicago-based former options trader, who started MWS in 2003 as a side business until kicking it off fully in 2012, oversees $157 million for high net-wealth clients. He said the firm's ...

LCGC EAB member Paul Ferguson has been named a professor by special appointment at the Faculty of Science at the University ...

The company reported adjusted earnings per share of $0.28 on revenue of $586 million – a significant rise compared to last ...